Travel-associated cases of Legionnaires' disease in the United States, 2015-2016

Travel Med Infect Dis. 2021 Mar-Apr:40:101943. doi: 10.1016/j.tmaid.2020.101943. Epub 2020 Dec 3.

Abstract

Background: Recent travel is associated with ~20% of reported Legionnaires' disease (LD) cases worldwide.

Methods: We analyzed LD cases reported to the Centers for Disease Control and Prevention (CDC) during 2015-2016. Travel-associated cases met case criteria for confirmed LD in someone who spent ≥1 night away from home during the 10 days before symptom onset. Most analyses were limited to travel-associated, public accommodation stay (TAPAS) cases. We used reported travel dates to estimate the number of TAPAS cases acquired during travel.

Results: Of 12,200 LD cases reported among U.S. residents, 12.3% were travel-associated; 8.7% were TAPAS. Median patient age for TAPAS cases was 61 years; 64.4% were male; 67.3% were white; 77.9% were non-Hispanic; 96.1% were hospitalized; 4.5% died. Among 887 TAPAS cases involving U.S. destinations, an estimated 29.8% were acquired during travel; 4.28 TAPAS cases were reported, and an estimated 1.10 TAPAS cases were acquired during travel, per 10,000,000 hotel room nights booked. Sixty-eight U.S. TAPAS clusters were detected.

Conclusions: While acquisition during travel accounted for a relatively small proportion of all LD cases, clusters of TAPAS cases were frequently detected. Prompt notification of these cases to CDC facilitates cluster detection and expedites intervention.

Keywords: Hotel; Legionnaires' disease; Travel.

MeSH terms

  • Centers for Disease Control and Prevention, U.S.
  • Disease Outbreaks
  • Female
  • Humans
  • Legionnaires' Disease* / epidemiology
  • Male
  • Middle Aged
  • Population Surveillance
  • Travel
  • United States / epidemiology